|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM11270431X |
003 |
DE-627 |
005 |
20231222162322.0 |
007 |
tu |
008 |
231222s1997 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed24n0376.xml
|
035 |
|
|
|a (DE-627)NLM11270431X
|
035 |
|
|
|a (NLM)11364445
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
245 |
1 |
0 |
|a Expanded access and patient assistance programs for other experimental drugs from their manufacturers
|
264 |
|
1 |
|c 1997
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 09.07.1997
|
500 |
|
|
|a Date Revised 17.11.2004
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Directory
|
650 |
|
4 |
|a Newspaper Article
|
650 |
|
7 |
|a Drugs, Investigational
|2 NLM
|
773 |
0 |
8 |
|i Enthalten in
|t Critical Path AIDS project
|d 1994-1995
|g (1997), No 32 vom: 06., Seite 44-64
|w (DE-627)NLM098213636
|x 1085-7605
|7 nnns
|
773 |
1 |
8 |
|g year:1997
|g number:No 32
|g day:06
|g pages:44-64
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|j 1997
|e No 32
|b 06
|h 44-64
|